Co-Diagnostics Shares Rise 21% After Submitting FDA Application For Covid-19 Test Platform

By Ben Glickman Shares of Co-Diagnostics rose on Wednesday after the company submitted an application to the Food and Drug Administration for its Covid-19...

Related Keywords

Ben Glickman ,Drug Administration ,Salt Lake City Based ,Emergency Use ,Article Normal ,Regulation Government Policy ,Financial Performance ,Share Price Movement Disruptions ,New Products Services ,Product Service Approvals ,Corporate Industrial News ,Products Services ,Political General News ,Respiratory Tract Diseases ,Health ,Medical Conditions ,Outbreaks Epidemics ,Novel Coronaviruses ,Infectious Diseases ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Us1897631057 ,Codx ,Regulation ,Government Policy ,Share Price Movement ,Disruptions ,New Products ,Services ,Product ,Service Approvals ,Corporate ,Industrial News ,Products ,Political ,General News ,Outbreaks ,Epidemics ,Commodity ,Financial Market News ,